GlassScriptPhysician profile
Vikas Gupta
NPI 1003032111
$2,750.62
in general payments reported to CMS, 2019-2025
14 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $51.88 · 2021: $290 · 2022: $703 · 2023: $545 · 2024: $41.14 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,225 · Food and Beverage: $344 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,225.38 |
| Food and Beverage | $344.28 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $1,544.48 | 2020-2025 | Web Aneurysm Embolization System, Stent |
| Stryker Corporation | $208.09 | 2019-2022 | |
| Genzyme Corporation | $186.86 | 2021 | |
| Medtronic, INC. | $174.39 | 2022-2023 | Rist, Reacttm |
| Penumbra, INC. | $137.54 | 2020-2023 | Penumbra System, Red 72 |
| Imperative Care, INC | $111.21 | 2022 | |
| Siemens Medical Solutions USA, INC. | $91.26 | 2022 | |
| Depuy Synthes Sales INC. | $88.96 | 2022 | |
| Ucb, INC. | $71.11 | 2025 | Nayzilam |
| Qapel Medical INC | $42.31 | 2022 | |
| Alkermes, INC. | $42.03 | 2021 | |
| Hologic Sales and Service, LLC | $21.14 | 2024 | Coolseal Generator |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Otsuka America Pharmaceutical, INC. | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.